Gall Matthew — Chief Financial Officer
Insider trading activity for Gall Matthew sourced from SEC EDGAR Form 4 filings.
Overview
- Title: Chief Financial Officer
- Company: Tango Therapeutics, Inc.
- Total insider trades: 3
- Total buy volume: $0
- Total sell volume: $0
- Last trade: May 5, 2026
Recent Trades
| Date | Insider | Ticker / Company | Type | Shares | Value |
|---|---|---|---|---|---|
| May 1, 2026 | Gall Matthew | TNGX Tango Therapeutics, Inc. | OTHER | 240,000 | N/A |
| May 1, 2026 | Gall Matthew | TNGX Tango Therapeutics, Inc. | OTHER | 40,000 | N/A |
| Mar 19, 2026 | Gall Matthew | KLRS Kalaris Therapeutics, Inc. | OTHER | 95,000 | N/A |